{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:39:27Z","timestamp":1790235567138,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"crossref","award":["PERIS, SLT017\/20\/000197"],"award-info":[{"award-number":["PERIS, SLT017\/20\/000197"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"crossref","award":["PERIS, SLT017\/20\/000197"],"award-info":[{"award-number":["PERIS, SLT017\/20\/000197"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["RD21\/0006\/0014"],"award-info":[{"award-number":["RD21\/0006\/0014"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["RD16\/0019\/0021"],"award-info":[{"award-number":["RD16\/0019\/0021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["RD21\/0006\/0007"],"award-info":[{"award-number":["RD21\/0006\/0007"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"crossref","award":["2021-SGR-0656"],"award-info":[{"award-number":["2021-SGR-0656"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21936-0","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:33:45Z","timestamp":1761831225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identifying new blood biomarkers of neuroplasticity associated with rehabilitation outcomes after stroke"],"prefix":"10.1038","volume":"15","author":[{"given":"Nicol\u00e1s","family":"Garcia-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Garcia-Gabilondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Ignacio","family":"Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuberoa Maite","family":"Miranda-Artieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e0lia","family":"Ridao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bux\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Engracia","family":"P\u00e9rez-Mesquida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosario","family":"Beseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan B.","family":"Salom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Inzitari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Otero-Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Martin-Mourelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Molleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Valor-Blanquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Lamana-Vallverd\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Penalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"21936_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and National burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 20 (10), 795\u2013820. https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0 (2021).","DOI":"10.1016\/S1474-4422(21)00252-0"},{"issue":"9778","key":"21936_CR2","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(11)60325-5","volume":"377","author":"P Langhorne","year":"2011","unstructured":"Langhorne, P., Bernhardt, J. & Kwakkel, G. Stroke rehabilitation. Lancet 377 (9778), 1693\u20131702. https:\/\/doi.org\/10.1016\/S0140-6736(11)60325-5 (2011).","journal-title":"Lancet"},{"issue":"1","key":"21936_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/STROKEAHA.122.041729","volume":"54","author":"LG Richards","year":"2023","unstructured":"Richards, L. G. & Cramer, S. C. Therapies targeting stroke recovery. Stroke 54 (1), 265\u2013269. https:\/\/doi.org\/10.1161\/STROKEAHA.122.041729 (2023).","journal-title":"Stroke"},{"issue":"4","key":"21936_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S1474-4422(19)30415-6","volume":"19","author":"CM Stinear","year":"2020","unstructured":"Stinear, C. M., Lang, C. E., Zeiler, S. & Byblow, W. D. Advances and challenges in stroke rehabilitation. Lancet Neurol. 19 (4), 348\u2013360. https:\/\/doi.org\/10.1016\/S1474-4422(19)30415-6 (2020).","journal-title":"Lancet Neurol."},{"key":"21936_CR5","doi-asserted-by":"publisher","unstructured":"Bayes-Genis, A. et al. at al. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. Eur J Heart Fail. ;25(11):1891\u20131898. (2023). https:\/\/doi.org\/10.1002\/ejhf.3036","DOI":"10.1002\/ejhf.3036"},{"key":"21936_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejim.2025.04.027","volume":"137","author":"N P\u00e9rez-Sol\u00e9","year":"2025","unstructured":"P\u00e9rez-Sol\u00e9, N. et al. NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction. Eur. J. Intern. Med. 137, 83\u201389. https:\/\/doi.org\/10.1016\/j.ejim.2025.04.027 (2025).","journal-title":"Eur. J. Intern. Med."},{"key":"21936_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijcard.2022.03.052","volume":"15","author":"TF Imran","year":"2022","unstructured":"Imran, T. F. et al. NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy. Int. J. Cardiol. 15, 357:48\u201354. https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.052 (2022).","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"21936_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41582-020-0350-6","volume":"16","author":"J Montaner","year":"2020","unstructured":"Montaner, J. et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat. Rev. Neurol. 16 (5), 247\u2013264. https:\/\/doi.org\/10.1038\/s41582-020-0350-6 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"21936_CR9","doi-asserted-by":"publisher","first-page":"175628641878934","DOI":"10.1177\/1756286418789340","volume":"6","author":"L Ramiro","year":"2018","unstructured":"Ramiro, L., Simats, A., Garc\u00eda-Berrocoso, T. & Montaner, J. Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management. Ther. Adv. Neurol. Disord. 6, 11:1756286418789340. https:\/\/doi.org\/10.1177\/1756286418789340 (2018).","journal-title":"Ther. Adv. Neurol. Disord"},{"issue":"6","key":"21936_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/brainsci13060846","volume":"13","author":"L W\u0142odarczyk","year":"2023","unstructured":"W\u0142odarczyk, L. et al. IGF-1 and MMP-9 and expression of their genes as potential prognostic markers of recovery in Post-Stroke Rehabilitation-A prospective observational study. Brain Sci. 13 (6), 846. https:\/\/doi.org\/10.3390\/brainsci13060846 (2023).","journal-title":"Brain Sci."},{"issue":"8","key":"21936_CR11","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.apmr.2021.04.010","volume":"102","author":"NS Limaye","year":"2021","unstructured":"Limaye, N. S., Carvalho, L. B. & Kramer, S. Effects of aerobic exercise on serum biomarkers of neuroplasticity and brain repair in stroke: A systematic review. Arch. Phys. Med. Rehabil. 102 (8), 1633\u20131644. https:\/\/doi.org\/10.1016\/j.apmr.2021.04.010 (2021).","journal-title":"Arch. Phys. Med. Rehabil"},{"key":"21936_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fneur.2018.00508","volume":"9","author":"M Gabriel-Salazar","year":"2018","unstructured":"Gabriel-Salazar, M. et al. Importance of angiogenin and endothelial progenitor cells after rehabilitation both in ischemic stroke patients and in a mouse model of cerebral ischemia. Front. Neurol. 9, 508. https:\/\/doi.org\/10.3389\/fneur.2018.00508 (2018).","journal-title":"Front. Neurol."},{"issue":"11","key":"21936_CR13","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.apmr.2016.06.007","volume":"97","author":"F Ma","year":"2016","unstructured":"Ma, F. et al. Plasma matrix metalloproteinases in patients with stroke during intensive rehabilitation therapy. Arch. Phys. Med. Rehabil. 97 (11), 1832\u20131840. https:\/\/doi.org\/10.1016\/j.apmr.2016.06.007 (2016).","journal-title":"Arch. Phys. Med. Rehabil"},{"key":"21936_CR14","doi-asserted-by":"publisher","first-page":"662235","DOI":"10.3389\/fneur.2021.662235","volume":"12","author":"M Gabriel-Salazar","year":"2021","unstructured":"Gabriel-Salazar, M. et al. Angiogenin in the neurogenic subventricular zone after stroke. Front. Neurol. 12, 662235. https:\/\/doi.org\/10.3389\/fneur.2021.662235 (2021).","journal-title":"Front. Neurol."},{"key":"21936_CR15","doi-asserted-by":"publisher","first-page":"767484","DOI":"10.3389\/fneur.2021.767484","volume":"12","author":"N Garcia-Rodriguez","year":"2021","unstructured":"Garcia-Rodriguez, N. et al. Functional recovery and serum angiogenin changes according to intensity of rehabilitation therapy after stroke. Front. Neurol. 12, 767484. https:\/\/doi.org\/10.3389\/fneur.2021.767484 (2021).","journal-title":"Front. Neurol."},{"issue":"3","key":"21936_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1134\/s0006297907030017","volume":"72","author":"AV Digtyar","year":"2007","unstructured":"Digtyar, A. V., Pozdnyakova, N. V., Feldman, N. B., Lutsenko, S. V. & Severin, S. E. Endostatin: current concepts about its biological role and mechanisms of action. Biochem. (Mosc). 72 (3), 235\u2013246. https:\/\/doi.org\/10.1134\/s0006297907030017 (2007).","journal-title":"Biochem. (Mosc)"},{"issue":"2","key":"21936_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0092-8674(00)81848-6","volume":"88","author":"MS O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly, M. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (2), 277\u2013285. https:\/\/doi.org\/10.1016\/s0092-8674(00)81848-6 (1997).","journal-title":"Cell"},{"issue":"9","key":"21936_CR18","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.RES.0000219899.93384.ed","volume":"98","author":"D Wenzel","year":"2006","unstructured":"Wenzel, D. et al. Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ. Res. 98 (9), 1203\u20131211. https:\/\/doi.org\/10.1161\/01.RES.0000219899.93384.ed (2006).","journal-title":"Circ. Res."},{"issue":"50","key":"21936_CR19","doi-asserted-by":"publisher","first-page":"13007","DOI":"10.1523\/JNEUROSCI.4323-06.2006","volume":"26","author":"JJ Ohab","year":"2006","unstructured":"Ohab, J. J., Fleming, S., Blesch, A. & Carmichael, S. T. A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26 (50), 13007\u201313016. https:\/\/doi.org\/10.1523\/JNEUROSCI.4323-06.2006 (2006).","journal-title":"J. Neurosci."},{"key":"21936_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2019.11.032","volume":"293","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Endostatin as a novel prognostic biomarker in acute ischemic stroke. Atherosclerosis 293, 42\u201348. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.11.032 (2020).","journal-title":"Atherosclerosis"},{"issue":"1","key":"21936_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2011.01.030","volume":"216","author":"M Navarro-Sobrino","year":"2011","unstructured":"Navarro-Sobrino, M. et al. A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke. Atherosclerosis 216 (1), 205\u2013211. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.01.030 (2011).","journal-title":"Atherosclerosis"},{"issue":"Pt 3","key":"21936_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.expneurol.2016.02.007","volume":"287","author":"ST Carmichael","year":"2017","unstructured":"Carmichael, S. T., Kathirvelu, B., Schweppe, C. A. & Nie, E. H. Molecular, cellular and functional events in axonal sprouting after stroke. Exp. Neurol. 287 (Pt 3), 384\u2013394. https:\/\/doi.org\/10.1016\/j.expneurol.2016.02.007 (2017).","journal-title":"Exp. Neurol."},{"key":"21936_CR23","doi-asserted-by":"publisher","first-page":"134412","DOI":"10.1016\/j.neulet.2019.134412","volume":"711","author":"SJ Li","year":"2019","unstructured":"Li, S. J. et al. EPO promotes axonal sprouting by upregulating GDF10. Neurosci. Lett. 711, 134412. https:\/\/doi.org\/10.1016\/j.neulet.2019.134412 (2019).","journal-title":"Neurosci. Lett."},{"issue":"12","key":"21936_CR24","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/nn.4146","volume":"18","author":"S Li","year":"2015","unstructured":"Li, S. et al. GDF10 is a signal for axonal sprouting and functional recovery after stroke. Nat. Neurosci. 18 (12), 1737\u20131745. https:\/\/doi.org\/10.1038\/nn.4146 (2015).","journal-title":"Nat. Neurosci."},{"issue":"4","key":"21936_CR25","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4103\/1673-5374.266904","volume":"15","author":"M Yepes","year":"2020","unstructured":"Yepes, M. Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain. Neural Regen Res. 15 (4), 620\u2013624. https:\/\/doi.org\/10.4103\/1673-5374.266904 (2020).","journal-title":"Neural Regen Res."},{"issue":"43","key":"21936_CR26","doi-asserted-by":"publisher","first-page":"14219","DOI":"10.1523\/JNEUROSCI.5309-13.2014","volume":"34","author":"F Wu","year":"2014","unstructured":"Wu, F. et al. Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke. J. Neurosci. 34 (43), 14219\u201314232. https:\/\/doi.org\/10.1523\/JNEUROSCI.5309-13.2014 (2014).","journal-title":"J. Neurosci."},{"issue":"43","key":"21936_CR27","doi-asserted-by":"publisher","first-page":"10310","DOI":"10.1523\/JNEUROSCI.1630-17.2017","volume":"37","author":"A Diaz","year":"2017","unstructured":"Diaz, A. et al. A cross talk between neuronal Urokinase-type plasminogen activator (uPA) and astrocytic uPA receptor (uPAR) promotes astrocytic activation and synaptic recovery in the ischemic brain. J. Neurosci. 37 (43), 10310\u201310322. https:\/\/doi.org\/10.1523\/JNEUROSCI.1630-17.2017 (2017).","journal-title":"J. Neurosci."},{"issue":"3","key":"21936_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","volume":"268","author":"J Eugen-Olsen","year":"2010","unstructured":"Eugen-Olsen, J. et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J. Intern. Med. 268 (3), 296\u2013308. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02252.x (2010).","journal-title":"J. Intern. Med."},{"issue":"1","key":"21936_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/STROKEAHA.113.003305","volume":"45","author":"M Persson","year":"2014","unstructured":"Persson, M. et al. Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease. Stroke 45 (1), 18\u201323. https:\/\/doi.org\/10.1161\/STROKEAHA.113.003305 (2014).","journal-title":"Stroke"},{"issue":"3","key":"21936_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.21873\/invivo.11070","volume":"31","author":"J Onatsu","year":"2017","unstructured":"Onatsu, J. et al. Soluble Urokinase-type plasminogen activator receptor predicts All-cause 5-Year mortality in ischemic stroke and TIA. Vivo 31 (3), 381\u2013386. https:\/\/doi.org\/10.21873\/invivo.11070 (2017).","journal-title":"Vivo"},{"issue":"Suppl 1","key":"21936_CR31","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri, S. The STROBE guidelines. Saudi J. Anaesth. 13 (Suppl 1), S31\u2013S34. https:\/\/doi.org\/10.4103\/sja.SJA_543_18 (2019).","journal-title":"Saudi J. Anaesth."},{"key":"21936_CR32","unstructured":"Ag\u00e8ncia d\u2019Avaluaci\u00f3 de Tecnologia i Recerca M\u00e8diques. (2007). Available from: https:\/\/scientiasalut.gencat.cat\/handle\/11351\/1853"},{"issue":"1","key":"21936_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3233\/RNN-190978","volume":"38","author":"RW Regenhardt","year":"2020","unstructured":"Regenhardt, R. W., Takase, H., Lo, E. H. & Lin, D. J. Translating concepts of neural repair after stroke: structural and functional targets for recovery. Restor. Neurol. Neurosci. 38 (1), 67\u201392. https:\/\/doi.org\/10.3233\/RNN-190978 (2020).","journal-title":"Restor. Neurol. Neurosci."},{"issue":"1","key":"21936_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41583-020-00396-7","volume":"22","author":"MT Joy","year":"2021","unstructured":"Joy, M. T. & Carmichael, S. T. Encouraging an excitable brain state: mechanisms of brain repair in stroke. Nat. Rev. Neurosci. 22 (1), 38\u201353. https:\/\/doi.org\/10.1038\/s41583-020-00396-7 (2021).","journal-title":"Nat. Rev. Neurosci."},{"key":"21936_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semcdb.2018.12.003","volume":"95","author":"BL Marques","year":"2019","unstructured":"Marques, B. L. et al. The role of neurogenesis in neurorepair after ischemic stroke. Semin Cell. Dev. Biol. 95, 98\u2013110. https:\/\/doi.org\/10.1016\/j.semcdb.2018.12.003 (2019).","journal-title":"Semin Cell. Dev. Biol."},{"issue":"5","key":"21936_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/1747493017714176","volume":"12","author":"LA Boyd","year":"2017","unstructured":"Boyd, L. A. et al. Biomarkers of stroke recovery: Consensus-based core recommendations from the stroke recovery and rehabilitation roundtable. Int. J. Stroke. 12 (5), 480\u2013493. https:\/\/doi.org\/10.1177\/1747493017714176 (2017).","journal-title":"Int. J. Stroke"},{"issue":"10","key":"21936_CR37","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S1474-4422(17)30283-1","volume":"16","author":"CM Stinear","year":"2017","unstructured":"Stinear, C. M. Prediction of motor recovery after stroke: advances in biomarkers. Lancet Neurol. 16 (10), 826\u2013836. https:\/\/doi.org\/10.1016\/S1474-4422(17)30283-1 (2017).","journal-title":"Lancet Neurol."},{"issue":"2","key":"21936_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/08977199509028956","volume":"12","author":"NS Cunningham","year":"1995","unstructured":"Cunningham, N. S. et al. Growth\/differentiation factor-10: a new member of the transforming growth factor-beta superfamily related to bone morphogenetic protein-3. Growth Factors. 12 (2), 99\u2013109. https:\/\/doi.org\/10.3109\/08977199509028956 (1995).","journal-title":"Growth Factors"},{"issue":"1","key":"21936_CR39","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41598-024-51635-1","volume":"14","author":"TR Yousof","year":"2024","unstructured":"Yousof, T. R., Mejia-Benitez, A., Morrison, K. M. & Austin, R. C. Reduced plasma GDF10 levels are positively associated with cholesterol impairment and childhood obesity. Sci. Rep. 14 (1), 1805. https:\/\/doi.org\/10.1038\/s41598-024-51635-1 (2024).","journal-title":"Sci. Rep."},{"issue":"2","key":"21936_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.17756\/jnen.2018-039","volume":"4","author":"P Merino","year":"2018","unstructured":"Merino, P. & Yepes, M. Urokinase-type plasminogen activator induces neurorepair in the ischemic brain. J. Neurol. Exp. Neurosci. 4 (2), 24\u201329. https:\/\/doi.org\/10.17756\/jnen.2018-039 (2018).","journal-title":"J. Neurol. Exp. Neurosci."},{"issue":"6","key":"21936_CR41","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/biomedicines10061346","volume":"10","author":"S Dzhauari","year":"2022","unstructured":"Dzhauari, S. et al. Urokinase-Type plasminogen activator enhances the neuroprotective activity of Brain-Derived neurotrophic factor in a model of intracerebral hemorrhage. Biomedicines 10 (6), 1346. https:\/\/doi.org\/10.3390\/biomedicines10061346 (2022).","journal-title":"Biomedicines"},{"key":"21936_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-018-0141-8","volume":"16","author":"TH Haupt","year":"2019","unstructured":"Haupt, T. H. et al. Healthy lifestyles reduce SuPAR and mortality in a Danish general population study. Immun. Aging. 16, 1. https:\/\/doi.org\/10.1186\/s12979-018-0141-8 (2019).","journal-title":"Immun. Aging"},{"key":"21936_CR43","doi-asserted-by":"publisher","first-page":"780641","DOI":"10.3389\/fimmu.2021.780641","volume":"12","author":"LJH Rasmussen","year":"2021","unstructured":"Rasmussen, L. J. H., Petersen, J. E. V. & Eugen-Olsen, J. Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation. Front. Immunol. 12, 780641. https:\/\/doi.org\/10.3389\/fimmu.2021.780641 (2021).","journal-title":"Front. Immunol."},{"issue":"5","key":"21936_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1080\/1354750X.2020.1778090","volume":"25","author":"\u00d3M Peir\u00f3","year":"2020","unstructured":"Peir\u00f3, \u00d3. M. et al. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes. Biomarkers 25 (5), 402\u2013409. https:\/\/doi.org\/10.1080\/1354750X.2020.1778090 (2020).","journal-title":"Biomarkers"},{"key":"21936_CR45","doi-asserted-by":"publisher","first-page":"841024","DOI":"10.3389\/fneur.2022.841024","volume":"13","author":"TP Schmidt","year":"2022","unstructured":"Schmidt, T. P. et al. The role of soluble urokinase plasminogen activator receptor (suPAR) in the context of aneurysmal subarachnoid hemorrhage (aSAH)-A prospective observational study. Front. Neurol. 13, 841024. https:\/\/doi.org\/10.3389\/fneur.2022.841024 (2022).","journal-title":"Front. Neurol."},{"issue":"1","key":"21936_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neulet.2007.12.004","volume":"432","author":"N Nagai","year":"2008","unstructured":"Nagai, N. et al. Urokinase-type plasminogen activator receptor (uPAR) augments brain damage in a murine model of ischemic stroke. Neurosci. Lett. 432 (1), 46\u201349. https:\/\/doi.org\/10.1016\/j.neulet.2007.12.004 (2008).","journal-title":"Neurosci. Lett."},{"key":"21936_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.brainres.2010.09.023","volume":"1360","author":"A Al Ahmad","year":"2010","unstructured":"Al Ahmad, A. et al. Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in vitro. Brain Res. 1360, 28\u201339. https:\/\/doi.org\/10.1016\/j.brainres.2010.09.023 (2010).","journal-title":"Brain Res."},{"key":"21936_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.brainres.2018.08.010","volume":"1698","author":"A Angelidis","year":"2018","unstructured":"Angelidis, A. et al. Disrupted migration and proliferation of neuroblasts after postnatal administration of angiogenesis inhibitor. Brain Res. 1698, 121\u2013129. https:\/\/doi.org\/10.1016\/j.brainres.2018.08.010 (2018).","journal-title":"Brain Res."},{"issue":"3","key":"21936_CR49","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/jcm12031029","volume":"12","author":"W Borowicz","year":"2023","unstructured":"Borowicz, W., Ptaszkowski, K., Ptaszkowska, L., Murawska-Cia\u0142owicz, E. & Rosi\u0144czuk, J. Assessment of changes in serum C-Reactive protein levels in patients after ischemic stroke undergoing Rehabilitation-A retrospective observational study. J. Clin. Med. 12 (3), 1029. https:\/\/doi.org\/10.3390\/jcm12031029 (2023).","journal-title":"J. Clin. Med."},{"issue":"11","key":"21936_CR50","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1161\/STROKEAHA.119.026410","volume":"50","author":"T Uphaus","year":"2019","unstructured":"Uphaus, T. et al. NfL (Neurofilament light Chain) levels as a predictive marker for Long-Term outcome after ischemic stroke. Stroke 50 (11), 3077\u20133084. https:\/\/doi.org\/10.1161\/STROKEAHA.119.026410 (2019).","journal-title":"Stroke"},{"issue":"1","key":"21936_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/eci.12593","volume":"46","author":"J Eugen-Olsen","year":"2016","unstructured":"Eugen-Olsen, J., Ladelund, S. & S\u00f8rensen, L. T. Plasma SuPAR is Lowered by smoking cessation: a randomized controlled study. J. Clin. Invest. 46 (1), 59\u201364. https:\/\/doi.org\/10.1111\/eci.12593 (2016).","journal-title":"J. Clin. Invest."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21936-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21936-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21936-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:33:48Z","timestamp":1761831228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21936-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21936"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21936-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental protocols were approved by the following ethics committees under the following statement: Following the Declaration of Helsinki, previous approval of corresponding clinical research ethics committee sites was obtained: [Hospital Universitari Vall d\u2019Hebron PR(IR)317\/2013-PR(IR)346\/2016, PI16\/00981\/CEI: PI-17-056, Comit\u00e9 de \u00c9tica de Investigaci\u00f3n de A Coru\u00f1a-Ferrol 2017\u2009\u2212\u2009125, Corporaci\u00f3 Sanit\u00e0ria Parc Taul\u00ed de Sabadell 2017521, Hospital Universitario Polit\u00e9cnico La Fe 2016\/0727, Euskadi PI2016168]. All patients or their relatives provided written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"38047"}}